vs
Circle Internet Group, Inc.（CRCL）与MERIT MEDICAL SYSTEMS INC（MMSI）财务数据对比。点击上方公司名可切换其他公司
Circle Internet Group, Inc.的季度营收约是MERIT MEDICAL SYSTEMS INC的1.9倍（$739.8M vs $393.9M），Circle Internet Group, Inc.净利率更高（29.0% vs 9.6%，领先19.3%），Circle Internet Group, Inc.同比增速更快（5113.5% vs 10.9%），MERIT MEDICAL SYSTEMS INC自由现金流更多（$74.0M vs $-14.7M）
Circle是2013年由杰里米·阿莱尔与肖恩·内维尔联合创立的支付科技企业，目前总部位于美国纽约，核心业务覆盖稳定币发行，推出了锚定美元的USDC、锚定欧元的EURC两款稳定币，同时还发行有代币化货币市场基金产品USYC。
梅里特医疗系统公司是一家全球性医疗设备企业，设计、生产和销售适用于心脏病学、放射学、肿瘤学、内窥镜及重症监护领域的介入和诊断产品，为全球医院及医疗机构提供微创医疗解决方案，助力提升患者疗效和临床操作效率。
CRCL vs MMSI — 直观对比
营收规模更大
CRCL
是对方的1.9倍
$393.9M
营收增速更快
CRCL
高出5102.6%
10.9%
净利率更高
CRCL
高出19.3%
9.6%
自由现金流更多
MMSI
多$88.8M
$-14.7M
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $739.8M | $393.9M |
| 净利润 | $214.4M | $38.0M |
| 毛利率 | — | 49.6% |
| 营业利润率 | 11.0% | 13.8% |
| 净利率 | 29.0% | 9.6% |
| 营收同比 | 5113.5% | 10.9% |
| 净利润同比 | 202.0% | 36.0% |
| 每股收益（稀释后） | $0.64 | $0.64 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CRCLMMSI
| Q4 25 | — | $393.9M | ||
| Q3 25 | $739.8M | $384.2M | ||
| Q2 25 | $658.1M | $382.5M | ||
| Q1 25 | — | $355.4M | ||
| Q4 24 | — | $355.2M | ||
| Q3 24 | — | $339.8M | ||
| Q2 24 | $6.8M | $338.0M | ||
| Q1 24 | — | $323.5M |
净利润CRCLMMSI
| Q4 25 | — | $38.0M | ||
| Q3 25 | $214.4M | $27.8M | ||
| Q2 25 | $-482.1M | $32.6M | ||
| Q1 25 | — | $30.1M | ||
| Q4 24 | — | $27.9M | ||
| Q3 24 | — | $28.4M | ||
| Q2 24 | $32.9M | $35.7M | ||
| Q1 24 | — | $28.2M |
毛利率CRCLMMSI
| Q4 25 | — | 49.6% | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 48.2% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | 48.7% | ||
| Q3 24 | — | 46.4% | ||
| Q2 24 | — | 47.7% | ||
| Q1 24 | — | 46.9% |
营业利润率CRCLMMSI
| Q4 25 | — | 13.8% | ||
| Q3 25 | 11.0% | 11.1% | ||
| Q2 25 | -49.5% | 12.3% | ||
| Q1 25 | — | 11.5% | ||
| Q4 24 | — | 10.3% | ||
| Q3 24 | — | 11.0% | ||
| Q2 24 | — | 13.6% | ||
| Q1 24 | — | 11.1% |
净利率CRCLMMSI
| Q4 25 | — | 9.6% | ||
| Q3 25 | 29.0% | 7.2% | ||
| Q2 25 | -73.3% | 8.5% | ||
| Q1 25 | — | 8.5% | ||
| Q4 24 | — | 7.9% | ||
| Q3 24 | — | 8.4% | ||
| Q2 24 | 486.5% | 10.6% | ||
| Q1 24 | — | 8.7% |
每股收益（稀释后）CRCLMMSI
| Q4 25 | — | $0.64 | ||
| Q3 25 | $0.64 | $0.46 | ||
| Q2 25 | $-4.48 | $0.54 | ||
| Q1 25 | — | $0.49 | ||
| Q4 24 | — | $0.46 | ||
| Q3 24 | — | $0.48 | ||
| Q2 24 | $0.00 | $0.61 | ||
| Q1 24 | — | $0.48 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.3B | $446.4M |
| 总债务越低越好 | — | $734.0M |
| 股东权益账面价值 | $3.0B | $1.6B |
| 总资产 | $76.8B | $2.7B |
| 负债/权益比越低杠杆越低 | — | 0.46× |
8季度趋势，按日历期对齐
现金及短期投资CRCLMMSI
| Q4 25 | — | $446.4M | ||
| Q3 25 | $1.3B | $392.5M | ||
| Q2 25 | $1.1B | $341.8M | ||
| Q1 25 | — | $395.5M | ||
| Q4 24 | — | $376.7M | ||
| Q3 24 | — | $523.1M | ||
| Q2 24 | $457.5M | $636.7M | ||
| Q1 24 | — | $581.9M |
总债务CRCLMMSI
| Q4 25 | — | $734.0M | ||
| Q3 25 | — | $732.9M | ||
| Q2 25 | — | $731.8M | ||
| Q1 25 | — | $730.7M | ||
| Q4 24 | — | $729.6M | ||
| Q3 24 | — | $750.5M | ||
| Q2 24 | — | $801.3M | ||
| Q1 24 | — | $800.1M |
股东权益CRCLMMSI
| Q4 25 | — | $1.6B | ||
| Q3 25 | $3.0B | $1.5B | ||
| Q2 25 | $2.4B | $1.5B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | $460.9M | $1.3B | ||
| Q1 24 | — | $1.2B |
总资产CRCLMMSI
| Q4 25 | — | $2.7B | ||
| Q3 25 | $76.8B | $2.6B | ||
| Q2 25 | $64.2B | $2.6B | ||
| Q1 25 | — | $2.5B | ||
| Q4 24 | — | $2.4B | ||
| Q3 24 | — | $2.4B | ||
| Q2 24 | — | $2.4B | ||
| Q1 24 | — | $2.3B |
负债/权益比CRCLMMSI
| Q4 25 | — | 0.46× | ||
| Q3 25 | — | 0.48× | ||
| Q2 25 | — | 0.49× | ||
| Q1 25 | — | 0.51× | ||
| Q4 24 | — | 0.53× | ||
| Q3 24 | — | 0.57× | ||
| Q2 24 | — | 0.62× | ||
| Q1 24 | — | 0.65× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-10.7M | $98.5M |
| 自由现金流经营现金流 - 资本支出 | $-14.7M | $74.0M |
| 自由现金流率自由现金流/营收 | -2.0% | 18.8% |
| 资本支出强度资本支出/营收 | 0.5% | 6.2% |
| 现金转化率经营现金流/净利润 | -0.05× | 2.59× |
| 过去12个月自由现金流最近4个季度 | — | $215.7M |
8季度趋势，按日历期对齐
经营现金流CRCLMMSI
| Q4 25 | — | $98.5M | ||
| Q3 25 | $-10.7M | $75.0M | ||
| Q2 25 | $303.7M | $83.3M | ||
| Q1 25 | — | $40.6M | ||
| Q4 24 | — | $68.7M | ||
| Q3 24 | — | $47.3M | ||
| Q2 24 | — | $68.5M | ||
| Q1 24 | — | $36.2M |
自由现金流CRCLMMSI
| Q4 25 | — | $74.0M | ||
| Q3 25 | $-14.7M | $52.5M | ||
| Q2 25 | $296.3M | $69.6M | ||
| Q1 25 | — | $19.5M | ||
| Q4 24 | — | $65.3M | ||
| Q3 24 | — | $38.0M | ||
| Q2 24 | — | $57.9M | ||
| Q1 24 | — | $24.5M |
自由现金流率CRCLMMSI
| Q4 25 | — | 18.8% | ||
| Q3 25 | -2.0% | 13.7% | ||
| Q2 25 | 45.0% | 18.2% | ||
| Q1 25 | — | 5.5% | ||
| Q4 24 | — | 18.4% | ||
| Q3 24 | — | 11.2% | ||
| Q2 24 | — | 17.1% | ||
| Q1 24 | — | 7.6% |
资本支出强度CRCLMMSI
| Q4 25 | — | 6.2% | ||
| Q3 25 | 0.5% | 5.8% | ||
| Q2 25 | 1.1% | 3.6% | ||
| Q1 25 | — | 5.9% | ||
| Q4 24 | — | 1.0% | ||
| Q3 24 | — | 2.8% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | — | 3.6% |
现金转化率CRCLMMSI
| Q4 25 | — | 2.59× | ||
| Q3 25 | -0.05× | 2.70× | ||
| Q2 25 | — | 2.56× | ||
| Q1 25 | — | 1.35× | ||
| Q4 24 | — | 2.46× | ||
| Q3 24 | — | 1.66× | ||
| Q2 24 | — | 1.92× | ||
| Q1 24 | — | 1.28× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRCL
暂无分部数据
MMSI
| Other | $154.6M | 39% |
| Peripheral Intervention | $93.2M | 24% |
| Cardiac Intervention | $50.2M | 13% |
| OEM | $42.6M | 11% |
| Custom Procedural Solutions | $33.1M | 8% |
| Endoscopy Segment | $20.1M | 5% |
